Over 235 companies worldwide claim to offer contract manufacturing services for various types of biopharmaceutical drug / therapy products

Owing to the ever-increasing number of start-ups that are involved in R&D of novel biologics, there is an enormous opportunity for the CMOs in this domain. It is worth emphasizing that, since 2000, more than 115 new CMOs have been established in order to serve to the growing demand for novel biologics that have specific manufacturing requirements. The contemporary contract services market features a mix of large and small-sized CMOs and is characterized by multiple mergers and acquisitions as stakeholders strive to broaden their respective service portfolios. This has enabled several CMOs to offer end-to-end services, ranging from drug development, including preliminary R&D, preclinical and clinical trials, to commercial scale production and regulatory filings
 
To order this 750+ page report, which features 200+ figures and 250+ tables, please visit this link
 
The USD 13.9 billion (by 2030) financial opportunity within the biopharmaceutical manufacturing market has been analyzed across the following segments:
Commonly Outsourced Business Operations
Active Pharmaceutical Ingredients (API)
Finished Dosage Formulations (FDF)
Types of Expression System
Mammalian
Microbial
Others
Company Size
Small
Mid-Sized
Large and Very Large
Scale of Operation
Preclinical
Clinical
Commercial
Key Geographical Region
North America
Europe
Asia-Pacific
Rest of the World
 
The Biopharma Contract Manufacturing Market (3rd Edition), 2019-2030. report features the following companies, which we identified to be key players in this domain: 
3P Biopharmaceuticals
Abzena
Albany Molecular Research
BioVectra
BioXcellence (Boehringer Ingelheim)
Celonic
Charles River Laboratories
ChemPartner
Cobra Biologics
CordenPharma
Cytovance Biologics
GE Healthcare
Goodwin Biotechnology
Grand River Aseptic Manufacturing
IDT Biologika
KBI BioPharma
Kemwell Biopharma
LFB Biomanufacturing
Meridian Life Science
Patheon
Pfizer CentreOne
PX'Therapeutics
Samsung BioLogics
Sanofi, CEPiA
Thermo Fisher Scientific
Vetter Pharma International
 
Table of Contents
 
1. Preface

2. Executive Summary

3. Introduction


4. Competitive Landscape


5. Biopharmaceutical Contract Manufacturing in North America


6. Biopharmaceutical Contract Manufacturing in Europe


7. Biopharmaceutical Contract Manufacturing in Asia Pacific And the Rest of The World


8. Biopharmaceutical Contract Manufacturing in Asia Pacific And the Rest of The World
9. Case Study: Outsourcing of Biosimilars


10. Case Study: Comparison of Small Molecule and   Large Molecule Drugs / Therapies
11. Case Study on In-House Manufacturing


12. Collaborations


13. Recent Developments


14. Capacity Analysis
15. Demand Analysis
16. Market Forecast
17. SWOT Analysis
 
18.  Future of The Biopharmaceutical CMO Market
 
19.  Survey Analysis
 
20. Interview Transcripts
 
21. Appendix 1: List of Non-Industry Players
 
22. Appendix 1: List of Non-Industry Players
 
23. Appendix 3: List of Companies and Organizations
 
To purchase a copy, please visit https://rootsanalysis.com/reports/view_document/biopharma-contract-manufacturing-market-3rd-edition-2019-2030/250.html
 
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
[email protected]

You may also like

Discussion

No comments yet... Be the first to leave a reply! Login here

avatar
Johnshell
0 Karma
205 Posts

Board header image
Rootsanalysis
1 Subscribers
157 Posts

We provide market research and consulting in the pharmaceutical industry.

Made with by Mamby